IBB iShares Biotechnology ETF
IBB iShares Biotechnology ETF
Unknown sector · Unknown industry
Market read
Scan convergence 2 scans as of 2026-08-17 2 bull converging
POC $171.30 · VWAP $166.53 · +21.3% vs 12m avg buyer
Insiders no data — outside the Form 4 poll — US-filer feed only (foreign filers report via MAR managers'-transactions notices)
Coverage
1 related perspective
IBB Price Structure
Loading timeframes…
Peers
Every watchlist IBB belongs to, members best 30-day change first — IBB highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@biotech
@biotech-scan
@etf-ideas
News (last pull)
Headlines about IBB from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 58 days ago · Jun 21
- Biotech IPO window is opening but big pharma M&A still sets the pace, top bankers tell CNBC
- Equal-Weight ETFs Are the Play for Small-Cap Drug Development. Here's How to Position Now
- Biotech Stocks Are Up About 35% in the Past Year and Analysts Say the Biggest Gains Are Still Ahead
- Biotech Bloodbath Drags Health Care Down as MannKind and Soleno Stocks Sink
- Funding for Risky Biotechs Is Returning
IBB research tape
26 dated scans, research, and events, newest first — the full record.